Consensus Recommendations on the Use of Injectable Poly-L-Lactic Acid for Facial and Nonfacial Volum
Danny Vleggaar MD, Rebecca Fitzgerald MD, Z. Paul Lorenc MD FACS, J.Todd Andrews MD, Kimberly Butterwick MD, Jody Comstock MD, C. William Hanke MD, T. Gerald O'Daniel MD FACS, Melanie D. Palm MD MBA, Wendy E. Roberts MD, Neil Sadick MD, and Craig F. Tell
Poly-L-lactic acid (PLLA) was approved for use in Europe in 1999. In the United States, it was approved by the Food and Drug Administration in 2004 for the treatment of facial lipoatrophy associated with human immunodeficiency virus, and in 2009 for cosm
